One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Bispecific antibodies offer a “targeted and effective alternative” for the ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how ...

Antibodies are the immune system's precision tools for recognizing and neutralizing viruses, bacteria and other foreign ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Mode of action of the new microscopy method LLS-TDI-DNA-PAINT. On the top right, the RTX antibody was visualised on a Raij-B cell: it is easy to see how it links the CD20 molecules in the membrane.

When the body encounters an infectious agent like SARS-CoV-2, it produces antibodies that detect and neutralize it. The antibodies bind to distinct proteins on the virus’s surface called antigens. As ...

The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven have ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...

ST. LOUIS (KTVI) – Monoclonal antibody treatments received a thumbs up from a study by the Mayo Clinic released Monday. The study suggests the treatment can help those who are at high risk of serious ...

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells. Dr. Amany Keruakous sat down for an interview with CURE, in ...